2026年免疫組織化學（IHC）全球市場報告

近年來，免疫組織化學（IHC）市場發展迅速，預計將從2025年的27.6億美元成長到2026年的30.5億美元，複合年成長率（CAGR）為10.3%。過去幾年的成長可歸因於IHC在癌症診斷中應用日益廣泛、醫院病理檢查室規模擴大、單株抗體供應增加、組織學診斷方法的普及以及臨床研究活動的增加。

預計未來幾年免疫組織化學 (IHC) 市場將快速成長，到 2030 年市場規模將達到 44.7 億美元，複合年成長率 (CAGR) 為 10.1%。預測期內的成長要素包括：對精準腫瘤診斷的需求不斷成長、人工智慧病理分析的日益普及、生物標記主導藥物研發的進展、多重組織分析技術的廣泛應用以及對先進病理基礎設施投資的增加。預測期內的主要趨勢包括：自動化 IHC 染色系統的日益普及、多重 I​​HC 技術的廣泛應用、數位病理平台的日益整合、伴隨診斷應用的擴展以及對高特異性抗體的日益關注。

未來幾年，對個人化醫療日益成長的需求預計將推動免疫組織化學 (IHC) 市場的成長。個人化醫療是指根據患者的基因組成、環境因素和生活方式，客製化醫療決策、治療方法和產品的醫療方法。免疫組織化學在這一方法中發揮關鍵作用，它能夠識別特定的蛋白質生物標記物，從而有助於腫瘤的準確分類和診斷。例如，根據美國非營利研究機構個人化醫療聯盟 (Personalized Medicine Coalition) 的數據顯示，截至 2024 年 2 月，美國食品藥物管理局(FDA) 2023 年新核准中，超過三分之一是與個人化醫療相關的產品。同年，FDA核准了16 種針對罕見疾病患者的新型個人化治療方法，較 2022 年的 6 種顯著增加。因此，個人化醫療的日益普及正在推動免疫組織化學市場的成長。

免疫組織化學 (IHC) 市場的主要企業致力於透過創新技術和高品質試劑來提高診斷準確性，從而增強組織分析在各種臨床和研究環境中的有效性。 Neoflex 多體學質譜成像 (MSI) 系統是一個尖端的成像平台，專為精確的組織分析而設計，使研究人員能夠利用高解析度質譜技術對組織內的生物分子進行空間定位，從而將研究成果轉化為臨床應用。例如，2024 年 6 月，總部位於美國的科學儀器、分析和診斷解決方案開發商和製造商 Bruker 發布了 Neoflex 成像分析儀，該系統採用基質輔助雷射解吸/電離飛行時間(MALDI-TOF/TOF) 技術進行基於質譜的組織成像。 Neoflex MSI 系統滿足了從發現成像到臨床組織研究的進步需求。它配備了布魯克 10 kHz SmartBeam 3D 雷射器、改進的成像檢測器，並支援使用 SCiLS Scope 軟體輸出 OME-TIFF 檔案。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球免疫組織化學（IHC）市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧與自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 自動化免疫組織化學染色法系統的應用日益廣泛
  • 多重免疫組化技術的應用日益廣泛
  • 數位病理平台整合程度不斷提高
  • 擴大伴隨診斷應用範圍
  • 人們對高特異性抗體的興趣日益濃厚

第5章 終端用戶產業市場分析

• 醫院和診斷檢查室
• 研究所
• 製藥公司
• 生技公司
• CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球免疫組織化學（IHC）市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球免疫組織化學 (IHC) 市場規模、比較和成長率分析
• 全球免疫組織化學（IHC）市場表現：規模與成長，2020-2025年
• 全球免疫組織化學 (IHC) 市場預測：規模與成長，2025-2030 年，2035 年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 抗體、儀器、試劑和試劑盒
• 透過使用
• 診斷、藥物檢測及其他用途
• 最終用戶
• 醫院、診斷檢查室、研究實驗室和其他最終用戶
• 按類型細分：抗體
• 一抗、二抗、標記抗體
• 按類型細分：設備
• IHC染色系統、玻片掃描器、顯微鏡
• 按類型細分：試劑
• 檢測試劑、封閉試劑、封片劑
• 按類型細分：套裝
• 製備型免疫組織化學試劑盒、多重免疫組化試劑盒及特殊試劑盒

第10章 區域與國家分析

• 全球免疫組織化學 (IHC) 市場：區域分析、預測與趨勢，2020-2025 年、2025-2030 年預測、2035 年預測
• 全球免疫組織化學 (IHC) 市場：按國家、表現和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 免疫組織化學（IHC）市場：競爭格局與市場佔有率，2024年
• 免疫組織化學 (IHC) 市場：公司估值矩陣
• 免疫組織化學（IHC）市場：公司簡介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Merck Group
  • Danaher Corporation
  • PerkinElmer Inc.

第37章：其他領先和創新企業

• Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年免疫組織化學（IHC）市場：提供新機會的國家
• 2030年免疫組織化學（IHC）市場：充滿新機會的細分市場
• 2030年免疫組織化學（IHC）市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.

The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.

Tariffs are influencing the immunohistochemistry market by increasing costs of imported antibodies, reagents, staining systems, slide scanners, and imaging components used in diagnostic and research workflows. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-quality antibodies and equipment, while Asia-Pacific faces cost pressures in reagent exports. These tariffs are raising operational costs and delaying equipment upgrades. However, they are also supporting local antibody production, regional reagent manufacturing, and domestic development of automated IHC systems.

The immunohistochemistry (ihc) market research report is one of a series of new reports from The Business Research Company that provides immunohistochemistry (ihc) market statistics, including immunohistochemistry (ihc) industry global market size, regional shares, competitors with a immunohistochemistry (ihc) market share, detailed immunohistochemistry (ihc) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (ihc) industry. This immunohistochemistry (ihc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohistochemistry (ihc) market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing use of ihc in cancer diagnostics, expansion of hospital pathology laboratories, increased availability of monoclonal antibodies, rising adoption of tissue-based diagnostics, growing clinical research activities.

The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising adoption of ai-enabled pathology analysis, expansion of biomarker-driven drug development, growing use of multiplex tissue profiling, increasing investments in advanced pathology infrastructure. Major trends in the forecast period include increasing adoption of automated ihc staining systems, rising use of multiplex ihc techniques, growing integration of digital pathology platforms, expansion of companion diagnostic applications, enhanced focus on high-specificity antibodies.

The increasing demand for personalized medicines is anticipated to accelerate the growth of the immunohistochemistry (IHC) market in the coming years. Personalized medicine refers to a healthcare approach that customizes medical decisions, treatments, and products to individual patients based on their genetic makeup, environmental factors, and lifestyle attributes. Immunohistochemistry plays a crucial role in this approach by enabling the identification of specific protein biomarkers that support precise tumor classification and accurate diagnosis. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit research organization, personalized medicines represented more than one-third of all new approvals by the United States Food and Drug Administration in 2023. During the same year, the FDA approved 16 new personalized therapies for rare disease patients, compared to six approvals in 2022. As a result, the rising adoption of personalized medicines is contributing to the expansion of the immunohistochemistry market.

Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.

In December 2023, Danaher Corporation, a United States-based life sciences and diagnostics company, acquired Abcam plc for an undisclosed value. Through this acquisition, Danaher sought to broaden its portfolio of life science reagents and consumables, strengthen its protein analysis tools for both research and diagnostic applications, accelerate growth across the life sciences ecosystem, and enhance its global presence by offering more integrated solutions to researchers and healthcare professionals. Abcam plc is a United Kingdom-based biotechnology company specializing in antibodies, reagents, assays, and immunohistochemistry products.

Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech

North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohistochemistry (IHC) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohistochemistry (ihc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohistochemistry (ihc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Antibodies; Equipment; Reagents; Kits
• 2) By Applications: Diagnostics; Drug Testing; Other Applications
• 3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
• Subsegments:
• 1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies
• 2) By Equipment: IHC Staining Systems; Slide Scanners; Microscopes
• 3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
• 4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
• Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; Merck Group; Danaher Corporation; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB Inc.; Agilent Technologies Inc.; Abcam plc; Takara Bio Inc.; Biocare Medical LLC; Bio-Genex Laboratories; Diagnostic BioSystems Inc.; PHC Holdings Corporation; Leica Biosystems; Vector Laboratories; Ionpath Inc.; Reveal Biosciences; Akrivis Technologies Private Limited; LifeSpan BioSciences Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; GenScript Biotech
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Immunohistochemistry (IHC) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Immunohistochemistry (IHC) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Immunohistochemistry (IHC) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Immunohistochemistry (IHC) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics And Precision Medicine
  • 4.1.2 Artificial Intelligence And Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.4 Industry 4.0 And Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Automated Ihc Staining Systems
  • 4.2.2 Rising Use Of Multiplex Ihc Techniques
  • 4.2.3 Growing Integration Of Digital Pathology Platforms
  • 4.2.4 Expansion Of Companion Diagnostic Applications
  • 4.2.5 Enhanced Focus On High-Specificity Antibodies

5. Immunohistochemistry (IHC) Market Analysis Of End Use Industries

• 5.1 Hospitals And Diagnostic Laboratories
• 5.2 Research Institutes
• 5.3 Pharmaceutical Companies
• 5.4 Biotechnology Companies
• 5.5 Contract Research Organizations

6. Immunohistochemistry (IHC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunohistochemistry (IHC) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Immunohistochemistry (IHC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Immunohistochemistry (IHC) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Immunohistochemistry (IHC) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Immunohistochemistry (IHC) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunohistochemistry (IHC) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunohistochemistry (IHC) Market Segmentation

• 9.1. Global Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibodies, Equipment, Reagents, Kits
• 9.2. Global Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostics, Drug Testing, Other Applications
• 9.3. Global Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
• 9.4. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
• 9.5. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• IHC Staining Systems, Slide Scanners, Microscopes
• 9.6. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Detection Reagents, Blocking Reagents, Mounting Media
• 9.7. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

10. Immunohistochemistry (IHC) Market Regional And Country Analysis

• 10.1. Global Immunohistochemistry (IHC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Immunohistochemistry (IHC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunohistochemistry (IHC) Market

• 11.1. Asia-Pacific Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunohistochemistry (IHC) Market

• 12.1. China Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunohistochemistry (IHC) Market

• 13.1. India Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunohistochemistry (IHC) Market

• 14.1. Japan Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunohistochemistry (IHC) Market

• 15.1. Australia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunohistochemistry (IHC) Market

• 16.1. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunohistochemistry (IHC) Market

• 17.1. South Korea Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunohistochemistry (IHC) Market

• 18.1. Taiwan Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunohistochemistry (IHC) Market

• 19.1. South East Asia Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunohistochemistry (IHC) Market

• 20.1. Western Europe Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunohistochemistry (IHC) Market

• 21.1. UK Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunohistochemistry (IHC) Market

• 22.1. Germany Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunohistochemistry (IHC) Market

• 23.1. France Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunohistochemistry (IHC) Market

• 24.1. Italy Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunohistochemistry (IHC) Market

• 25.1. Spain Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunohistochemistry (IHC) Market

• 26.1. Eastern Europe Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunohistochemistry (IHC) Market

• 27.1. Russia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunohistochemistry (IHC) Market

• 28.1. North America Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunohistochemistry (IHC) Market

• 29.1. USA Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunohistochemistry (IHC) Market

• 30.1. Canada Immunohistochemistry (IHC) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunohistochemistry (IHC) Market

• 31.1. South America Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunohistochemistry (IHC) Market

• 32.1. Brazil Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunohistochemistry (IHC) Market

• 33.1. Middle East Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunohistochemistry (IHC) Market

• 34.1. Africa Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunohistochemistry (IHC) Market Regulatory and Investment Landscape

36. Immunohistochemistry (IHC) Market Competitive Landscape And Company Profiles

• 36.1. Immunohistochemistry (IHC) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Immunohistochemistry (IHC) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Immunohistochemistry (IHC) Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Immunohistochemistry (IHC) Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited

38. Global Immunohistochemistry (IHC) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

40. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies

• 40.1 Immunohistochemistry (IHC) Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Immunohistochemistry (IHC) Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Immunohistochemistry (IHC) Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer